Company has successfully developed key products in HALS series using in house R&D capabilities, at lab and pilot scale. The ongoing capex at Unit 3 is towards existing and new products. In Unit 3, Company is launching first line of production dedicated towards HALS series, which is expected to commercialize by H2 FY2023. Besides, additional production lines will also be installed in Unit 4 for manufacturing products under HALS series.
